These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 7526701)
1. Interleukin-1 receptor antagonist prevents sepsis-induced inhibition of protein synthesis. Cooney R; Owens E; Jurasinski C; Gray K; Vannice J; Vary T Am J Physiol; 1994 Nov; 267(5 Pt 1):E636-41. PubMed ID: 7526701 [TBL] [Abstract][Full Text] [Related]
2. Effect of central administration of interleukin-1 receptor antagonist on protein synthesis in skeletal muscle, kidney, and liver during sepsis. Lloyd CE; Palopoli M; Vary TC Metabolism; 2003 Sep; 52(9):1218-25. PubMed ID: 14506630 [TBL] [Abstract][Full Text] [Related]
3. Regulation of peptide-chain initiation in muscle during sepsis by interleukin-1 receptor antagonist. Vary TC; Voisin L; Cooney RN Am J Physiol; 1996 Sep; 271(3 Pt 1):E513-20. PubMed ID: 8843745 [TBL] [Abstract][Full Text] [Related]
4. Prevention of skeletal muscle catabolism in sepsis does not impair visceral protein metabolism. Cooney RN; Owens E; Slaymaker D; Vary TC Am J Physiol; 1996 Apr; 270(4 Pt 1):E621-6. PubMed ID: 8928768 [TBL] [Abstract][Full Text] [Related]
5. Reduced muscle protein breakdown in septic rats following treatment with interleukin-1 receptor antagonist. Zamir O; O'Brien W; Thompson R; Bloedow DC; Fischer JE; Hasselgren PO Int J Biochem; 1994 Jul; 26(7):943-50. PubMed ID: 8063018 [TBL] [Abstract][Full Text] [Related]
6. IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis. Lang CH; Fan J; Cooney R; Vary TC Am J Physiol; 1996 Mar; 270(3 Pt 1):E430-7. PubMed ID: 8638689 [TBL] [Abstract][Full Text] [Related]
7. Intracellular regulation of protein degradation during sepsis is different in fast- and slow-twitch muscle. Tiao G; Lieberman M; Fischer JE; Hasselgren PO Am J Physiol; 1997 Mar; 272(3 Pt 2):R849-56. PubMed ID: 9087646 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of IL-1 induced inhibition of protein synthesis in skeletal muscle. Cooney RN; Maish GO; Gilpin T; Shumate ML; Lang CH; Vary TC Shock; 1999 Apr; 11(4):235-41. PubMed ID: 10220298 [TBL] [Abstract][Full Text] [Related]
9. Sepsis-induced suppression of skeletal muscle translation initiation mediated by tumor necrosis factor alpha. Lang CH; Frost RA Metabolism; 2007 Jan; 56(1):49-57. PubMed ID: 17161226 [TBL] [Abstract][Full Text] [Related]
11. Amrinone prevents muscle protein wasting during chronic sepsis. Jurasinski CV; Kilpatrick L; Vary TC Am J Physiol; 1995 Mar; 268(3 Pt 1):E491-500. PubMed ID: 7534991 [TBL] [Abstract][Full Text] [Related]
12. Sepsis-induced changes in protein synthesis: differential effects on fast- and slow-twitch muscles. Vary TC; Kimball SR Am J Physiol; 1992 Jun; 262(6 Pt 1):C1513-9. PubMed ID: 1377447 [TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic blockade exacerbates sepsis-induced changes in tumor necrosis factor alpha and interleukin-6 in skeletal muscle and is associated with impaired translation initiation. Lang CH; Nystrom G; Frost RA J Trauma; 2008 Feb; 64(2):477-86. PubMed ID: 18301218 [TBL] [Abstract][Full Text] [Related]
14. IGF-I/IGFBP-3 binary complex modulates sepsis-induced inhibition of protein synthesis in skeletal muscle. Svanberg E; Frost RA; Lang CH; Isgaard J; Jefferson LS; Kimball SR; Vary TC Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1145-58. PubMed ID: 11052971 [TBL] [Abstract][Full Text] [Related]
15. Systemic delivery of the interleukin-1 receptor antagonist protein using a new strategy of direct adenoviral-mediated gene transfer to skeletal muscle capillary endothelium in the isolated rat hindlimb. Welling TH; Davidson BL; Zelenock JA; Stanley JC; Gordon D; Roessler BJ; Messina LM Hum Gene Ther; 1996 Oct; 7(15):1795-802. PubMed ID: 8894671 [TBL] [Abstract][Full Text] [Related]
16. TNF-binding protein ameliorates inhibition of skeletal muscle protein synthesis during sepsis. Cooney R; Kimball SR; Eckman R; Maish G; Shumate M; Vary TC Am J Physiol; 1999 Apr; 276(4):E611-9. PubMed ID: 10198295 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 receptor antagonist decreases cerebrospinal fluid nitric oxide levels and increases vasopressin secretion in the late phase of sepsis in rats. Wahab F; Tazinafo LF; Cárnio EC; Aguila FA; Batalhão ME; Rocha MJ Endocrine; 2015 May; 49(1):215-21. PubMed ID: 25338201 [TBL] [Abstract][Full Text] [Related]
18. Cytokine-triggered decreases in levels of phosphorylated eukaryotic initiation factor 4G in skeletal muscle during sepsis. Vary TC; Deiter G; Lang CH Shock; 2006 Dec; 26(6):631-6. PubMed ID: 17117141 [TBL] [Abstract][Full Text] [Related]
19. Effect of an interleukin-1 receptor antagonist on the hemodynamic manifestations of group B streptococcal sepsis. Vallette JD; Goldberg RN; Suguihara C; Del Moral T; Martinez O; Lin J; Thompson RC; Bancalari E Pediatr Res; 1995 Nov; 38(5):704-8. PubMed ID: 8552437 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor I accelerates protein synthesis in skeletal muscle during sepsis. Jurasinski CV; Vary TC Am J Physiol; 1995 Nov; 269(5 Pt 1):E977-81. PubMed ID: 7491951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]